$85.25
$0.00 (0.00%)
End-of-day quote: 05/03/2024
NYSE:EW

Edwards Lifesciences Corp Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$6.00B $5.38B $5.23B $4.39B $4.35B $3.72B $3.44B $2.96B $2.49B $2.32B $2.05B $1.90B $1.68B $1.45B $1.32B $1.24B $1.09B $1.04B $997.90M $931.50M
GM % Gross Margin %
77.02% 79.96% 76.13% 75.36% 74.37% 74.77% 74.52% 73.09% 75.25% 73.15% 74.74% 74.15% 70.82% 71.78% 69.80% 66.10% 65.34% 64.17% 62.46% 60.26%
OM Operating Margin
28.81% 33.29% 30.32% 30.01% 28.48% 28.82% 29.76% 27.65% 25.78% 21.30% 23.10% 22.10% 17.88% 19.65% 18.01% 16.02% 15.82% 16.89% 17.60% 16.58%
EPS Earnings Per Share
$0.00 $2.51 $2.48 $2.22 $1.86 $1.86 $1.57 $1.27 $0.96 $0.76 $0.58 $0.52 $0.45 $0.34 $0.31 $0.25 $0.21 $0.18 $0.17 $0.17 $0.14
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Sha. Shares
601.1m 608.3m 624.1m 624.3m 627.3m 623.1m 629.1m 634.8m 646.2m 646.8m 655.8m 685.8m 684.6m 690m 681.6m 670.8m 679.2m 692.4m 715.2m 713.26m
OCF Operating Cash Flow
$895.80M $1.22B $1.73B $1.05B $1.18B $926.70M $1.00B $704.40M $549.70M $1.02B $472.70M $362.10M $308.20M $251.40M $165.30M $153.20M $213.10M $232.70M $136.80M $180.60M
FCF Free Cash Flow
$1.11B $973.60M $1.41B $647.30M $925.00M $688.10M $832.60M $528.30M $447.00M $444.50M $364.10M $253.10M $183.20M $189.60M $101.30M $102.60M $156.10M $175.20M $88.30M $138.10M
FCFS Free Cash Flow Per Share
$1.04 $1.54 $2.25 $1.04 $1.45 $1.09 $1.30 $0.76 $0.69 $1.45 $0.54 $0.36 $0.33 $0.28 $0.15 $0.11 $0.22 $0.25 $0.12 $0.18